In vitro binding of the sequences necessary for notochord activity of
the Ci-tune CRM by the Ci-Bra and Ci-FoxA-a proteins. (A)
Electrophoretic mobility shift assays (EMSA) with a radiolabeled probe
containing the predicted Ci-FoxA-a binding site and a GST-Ci-FoxA-a fusion
protein. Lanes contained: (1,2) radiolabeled probe containing the predicted
Ci-FoxA-a binding site, (1) free, and (2) incubated with the GST-Ci-FoxA-a
fusion protein; (3,4) radiolabeled probe containing the mutated Ci-FoxA-a
binding site, (3) free, and (4) incubated with GST-Ci-FoxA-a; (5-12)
radiolabeled probe containing the predicted Ci-FoxA-a binding site and
unlabeled competitors, at 1 μM (lanes 5,7,9,11) and 5 μM (lanes
6,8,10,12) concentrations, incubated with GST-Ci-FoxA-a. (B) EMSA with
radiolabeled probe and a GST-Ci-Bra fusion protein. Lanes contained: (13,14)
radiolabeled probe containing the predicted Ci-Bra binding site T-box site 1,
(13) free, and (14) incubated with GST-Ci-Bra fusion protein; (15-18)
radiolabeled T-box site 1 probe and unlabeled competitors, at 1 μM (lanes
15,17) and 5 μM (lanes 16,18) concentrations, incubated with
GST-Ci-Bra.